<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02537782</url>
  </required_header>
  <id_info>
    <org_study_id>S538235_v1.2</org_study_id>
    <nct_id>NCT02537782</nct_id>
  </id_info>
  <brief_title>Myocardial Work and Metabolism in CRT</brief_title>
  <acronym>WORK-CRT</acronym>
  <official_title>Investigating Inhomogeneities of Regional Myocardial WORKload and Metabolism in a Cardiac Resynchronisation Therapy Patient Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several attempts have been made to refine selection criteria for cardiac resynchronisation&#xD;
      therapy (CRT) in heart failure patients with reduced ejection fraction (HFrEF). Previously&#xD;
      proposed parameters probably do not sufficiently reflect the underlying mechanical&#xD;
      dyssynchrony of the left ventricle (LV). Earlier work of our research group suggests that&#xD;
      better candidate selection can rely on the direct observation or measurement of this LV&#xD;
      mechanical dyssynchrony by means of non-invasive imaging. In this study apical rocking and&#xD;
      other non-invasive measures of LV mechanical dyssynchrony will be applied to evaluate&#xD;
      regional myocardial workload and metabolism, and determine their predictive value in CRT&#xD;
      response.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Cardiac resynchronisation therapy (CRT) response assessed by echocardiography</measure>
    <time_frame>Change of left ventricular end-systolic volume (LVESV) between baseline and 6 months after CRT implantation</time_frame>
    <description>Reduction in LVESV ≥15% from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRT response assessed by echocardiography</measure>
    <time_frame>Change of LVESV between baseline and 12 months after CRT implantation</time_frame>
    <description>Reduction in LVESV ≥15% from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reverse left ventricular remodelling measured as changes in left ventricular volume by echocardiography</measure>
    <time_frame>Change of remodelling between baseline, 6 and 12 months after CRT implantation</time_frame>
    <description>Measured as changes in left ventricular volume by echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reverse left ventricular remodelling measured as changes in left ventricular ejection fraction by echocardiography</measure>
    <time_frame>Change of remodelling between baseline, 6 and 12 months after CRT implantation</time_frame>
    <description>Measured as changes in left ventricular ejection fraction by echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) class changes</measure>
    <time_frame>Change of NYHA class between baseline, 6 and 12 months after CRT implantation</time_frame>
    <description>A decrease of ≥1 NYHA class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity changes assessed by 6-minute walking test</measure>
    <time_frame>Change of functional capacity between baseline and 6 months after CRT implantation</time_frame>
    <description>Assessed by 6-minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity changes assessed by peak oxygen uptake ergospirometry (VO2max)</measure>
    <time_frame>Change of functional capacity between baseline and 6 months after CRT implantation</time_frame>
    <description>Assessed by peak oxygen uptake ergospirometry (VO2max)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life changes</measure>
    <time_frame>Change of QoL between baseline, 6 and 12 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure related hospital admissions</measure>
    <time_frame>Assessment of the number of hospital admissions at 6 and 12 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>Assessment of possible death at 6 and 12 months after CRT implantation</time_frame>
    <description>Death by heart failure, sudden cardiac death and all-cause death</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Left Ventricular Dyssynchrony</condition>
  <condition>Heart Failure</condition>
  <condition>Left Bundle Branch Block</condition>
  <condition>Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Cardiac resynchronisation therapy implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with current guideline-based indication for CRT implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac resynchronisation therapy</intervention_name>
    <arm_group_label>Cardiac resynchronisation therapy implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <arm_group_label>Cardiac resynchronisation therapy implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <arm_group_label>Cardiac resynchronisation therapy implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Positron Emission Tomography</intervention_name>
    <arm_group_label>Cardiac resynchronisation therapy implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        Subject is eligible for CRT implantation according to current European Society of&#xD;
        Cardiology guidelines of 2013.&#xD;
&#xD;
          -  The patient should receive guideline-directed optimal medical therapy for heart&#xD;
             failure and left ventricular (LV) function must be severely depressed (LV ejection&#xD;
             fraction ≤35%).&#xD;
&#xD;
          -  The patients should be in NYHA functional class II, III or ambulatory IV.&#xD;
&#xD;
          -  The patient should present a left bundle branch block (LBBB) with QRS duration of&#xD;
             &gt;120ms or a non-LBBB with QRS &gt;150ms.&#xD;
&#xD;
          -  Also patients with conventional pacemaker in NYHA functional class III and ambulatory&#xD;
             IV if high percentage of ventricular pacing, are eligible for CRT implantation.&#xD;
&#xD;
          -  Subject is in stable sinus rhythm at the time of CRT implant and during the last 2&#xD;
             weeks prior to inclusion.&#xD;
&#xD;
          -  Subject is 18 years or older and able and willing to consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Impossible to obtain LV volumes by echocardiography.&#xD;
&#xD;
          -  Right bundle branch block.&#xD;
&#xD;
          -  Permanent atrial fibrillation, flutter or tachycardia (&gt;100 bpm).&#xD;
&#xD;
          -  Recent myocardial infarction, within 40 days prior to enrolment.&#xD;
&#xD;
          -  Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90&#xD;
             days.&#xD;
&#xD;
          -  Post heart transplantation, or is actively listed on the transplantation list, or has&#xD;
             reasonable probability (per investigator's discretion) of undergoing transplantation&#xD;
             in the next year.&#xD;
&#xD;
          -  Implanted with a LV assist device (LVAD), or has reasonable probability (per&#xD;
             investigator's discretion) of receiving a LVAD in the next year.&#xD;
&#xD;
          -  Severe aortic stenosis (with a valve area of &lt;1.0 cm2 or significant valve disease&#xD;
             expected to be operated on within study period).&#xD;
&#xD;
          -  Complex and uncorrected congenital heart disease.&#xD;
&#xD;
          -  Breastfeeding women, women of child bearing potential.&#xD;
&#xD;
          -  Enrolled in one or more concurrent studies that would confound the results of this&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens-Uwe Voigt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Otto A Smiseth, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0372</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 12, 2015</study_first_submitted>
  <study_first_submitted_qc>August 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2015</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>prof. dr. Jens-Uwe Voigt</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <keyword>Cardiac Resynchronisation Therapy</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Left ventricular dyssynchrony</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Apical rocking</keyword>
  <keyword>Septal flash</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

